Ergebnis der Suchanfrage nach celle

Inhalte

Filtern
607 Treffer
  • 03.06.2020 – 10:00

    eleva GmbH

    Eleva's drug candidate to be examined for use in Covid-19 treatment

    Freiburg (ots) - Eleva, a manufacturer of superior biologics, is exploring the potential of one of its drug candidates for first-in-line therapy of Covid-19. The compound, factor H, is part of the complement system, which is believed to affect the severity of the course of Covid-19. Eleva has developed factor H previously for a different indication and taken it through ...

  • 13.05.2020 – 13:03

    Technische Universität München

    A disease trigger for pancreatitis has been identified

    TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161/ 71-5403 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36036/ High resolution images: https://mediatum.ub.tum.de/1545776 NEWS RELEASE A Calcium channel is involved in the development of pancreatitis A disease trigger for pancreatitis has been identified One factor ...

  • 29.04.2020 – 10:51

    Technische Universität München

    Improving immunotherapy for cancer

    TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161/ 71-5403 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36023/ High resolution images: https://mediatum.ub.tum.de/1544218 NEWS RELEASE Cause for the lack of immune defense against tumors discovered Improving immunotherapy for cancer One of the reasons why cancer develops is because regulatory cells inhibit the body's ...

  • 27.04.2020 – 14:01

    Technische Universität München

    In the hunt for new treatments against the coronavirus

    TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161/ 71-3207 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35999/ High resolution images: https://mediatum.ub.tum.de/1544195 In the hunt for new treatments against the coronavirus Researchers develop software for drug repurposing Currently, the corona pandemic is ...

  • 15.04.2020 – 14:43

    Technische Universität München

    Crohn's disease: Preserving inflammation-free phases

    TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161/ 71-5403 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35979/ High resolution images: https://mediatum.ub.tum.de/1543290 NEWS RELEASE Early detection of Crohn’s disease flare-ups leads to improved therapy options Preserving inflammation-free phases Crohn’s ...